.@CMSinnovates & @CMSGov today issued final #ROAPM rule. @ASTRO_org statement outlines problems including Jan 2021 start date, mandatory participation by zip & more. https://t.co/yqqnDEYl1v. #RadOnc @ASTRO_Chair @daveadler10 @HPAnnie2000

Profoundly disappointed with @CMSGov for the timing and content of the new Radiation Oncology payment model. Significant detriment to cancer care, risking the future viability of many practices providing critical care across the country. @SenatorShaheen @SenatorHassan

I am extremely disappointed with how the @ABR_Radiology has handled the current testing situation. The negative attention this continues to draw will certainly not help an already struggling specialty attract the next generation of Radoncs.

So much discussion of a worsening job market in #radonc, fueling medical student concerns and decreasing numbers of interested MS4s but where is the objective data that the job market is worse?? @DrChowdharyMD @jennamkahn @KenOlivierMD @DrLesterColl

Very interesting talk by @jennamkahn highlighting ways to engage #medstudent interested in #radonc via virtual elective in era of covid19. Wonder if others will adopt such an innovative model, and possibly offer as aways thru VSAS. #match21 #ROECSG @ASTRO_org @ARRO_org

Could the limitations for in person away rotations in #RadOnc be an opportunity for us to increase exposure to our specialty? @DrLesterColl @emmacfields @d_golden @SA_Rosenberg @RTendulkarMD

Medical students interested in #RadOnc are going to be limited on away rotations - see ADROP statement to AAMC - recommending home oncology rotations (med, surg, gyn, neuro-onc, ect) and connection with mentors. https://t.co/PqtP6cntFS @KenOlivierMD @emmacfields

Great work highlighting the more likely reality of the current situation.

Palliative #Radiotherapy for Oncologic Emergencies in the setting of #COVID19: Approaches to Balancing Risks and Benefits New guidelines for triage and treatment from the @sloan_kettering #radonc #pallonc #oligomet team. https://t.co/nLb0NaFzMP

Impact of Sequencing Radiation Therapy and Immune Checkpoint Inhibitors in the Treatment of Melanoma Brain Metastases. Excellent Work from my lab and Sengupta lab ( Emory and U of Cincinnati) ⁦@WinshipAtEmory⁩ ⁦@EmoryUniversity⁩

Further evidence to support high quality image-guided brachytherapy in cervical cancer with little to no benefit of completion hysterectomy.

Interesting review taking into account the biophysics of metastasis. Leaves me thinking, why don’t we see more extraneural spread of CNS tumors.

Great look at the evolution of program size with time!

New results of CATNON #SNO2019 (2x2 design of RT/TMZ/adj/concurr) Benefit of concurrent TMZ if IDH mutated, but not if IDHwt. Adjuvant TMZ more important than concurrent w/RT but both lead to best outcomes. We need better interventions for IDHwt patients! #btsm

This is great! Really one of the least talked about transitions, but potentially the most important.

Great opportunity to review and comment on this nicely put together clinical practice guideline for cervical cancer.

New #radonc residency grads reported varying levels of comfort w/ aspects critical to independent practice. Overall caseload and opportunity to independently review and make decisions about treatment plans during residency training were important. #MedED https://t.co/00bjD8KdPl

Osteosarcoma has challenged my faith, optimism, and resilience. It has also filled me with love, gratitude, and a deeper determination to improve cancer care. Here’s my reflection, published today in @JAMA_current:

Great to see our work assessing comfort of US radonc residents during the transition to independent practice, published. Thanks to our wonderful team of collaborators @SA_Rosenberg @d_golden @ErinGillespieMD @MalcolmMattes